Article Information
History
- November 21, 2023.
Article Versions
- Version 1 (November 2, 2023 - 09:20).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Adam Alexandersson1,2,6,*,
- Mikko S Venäläinen3,
- Nelli Heikkilä2,7,
- Xiaobo Huang2,
- Mervi Taskinen1,
- Pasi Huttunen1,6,
- Laura L Elo3,4,
- Minna Koskenvuo1 and
- Eliisa Kekäläinen2,5
- 1Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, New Children’s Hospital, Helsinki University Hospital, Helsinki, Finland
- 2Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland
- 3Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland
- 4Institute of Biomedicine, University of Turku, Turku, Finland
- 5HUS Diagnostic Center, Clinical microbiology, Helsinki University Hospital, Helsinki, Finland
- 6Children and Adolescents, Pediatric Research Center, New Children’s Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
- 7Center of Vaccinology, University of Geneva, Geneva, Switzerland
- ↵*Corresponding author Adam Alexandersson, Emil: adam.alexandersson{at}helsinki.fi, Address: Translational Immunology Research Program, PB 21, 00014 University of Helsinki, Finland, Phone: +358522051
Posted November 21, 2023.
Proteomics screening post pediatric allogeneic hematopoietic stem cell transplantation reveals an association between increased expression of inhibitory receptor FCRL6 on γδ T cells and CMV reactivation
